CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript: Complete molecular response to imatinib
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F05%3A00008624" target="_blank" >RIV/00216208:11110/05:00008624 - isvavai.cz</a>
Alternative codes found
RIV/00023736:_____/05:00006075 RIV/00064165:_____/05:00000365
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript: Complete molecular response to imatinib
Original language description
CML, BCR-ABL, molecular genetics
Czech name
CML pacient se vzácnou b2a3 (e13a3) variantou BCR-ABL transkriptu: Kompletní molekulární odpověď na imatinib
Czech description
CML, BCR-ABL, molekulární genetika
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NC7550" target="_blank" >NC7550: Role of BCR-ABL in CML cases with poor response to therapy but with low BCR-ABL transcript levels</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2005
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Leukemia Research
ISSN
0145-2126
e-ISSN
—
Volume of the periodical
2005
Issue of the periodical within the volume
29
Country of publishing house
GB - UNITED KINGDOM
Number of pages
2
Pages from-to
1365-1366
UT code for WoS article
—
EID of the result in the Scopus database
—